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Abstract
The regulation of complex cellular activities in palmitate treated HepG2 cells, and the ensuing cytotoxic phenotype, involves
cooperative interactions between genes. While previous approaches have largely focused on identifying individual target
genes, elucidating interacting genes has thus far remained elusive. We applied the concept of information synergy to
reconstruct a ‘‘gene-cooperativity’’ network for palmititate-induced cytotoxicity in liver cells. Our approach integrated gene
expression data with metabolic profiles to select a subset of genes for network reconstruction. Subsequent analysis of the
network revealed insulin signaling as the most significantly enriched pathway, and desmoplakin (DSP) as its top neighbor.
We determined that palmitate significantly reduces DSP expression, and treatment with insulin restores the lost expression
of DSP. Insulin resistance is a common pathological feature of fatty liver and related ailments, whereas loss of DSP has been
noted in liver carcinoma. Reduced DSP expression can lead to loss of cell-cell adhesion via desmosomes, and disrupt the
keratin intermediate filament network. Our findings suggest that DSP expression may be perturbed by palmitate and, along
with insulin resistance, may play a role in palmitate induced cytotoxicity, and serve as potential targets for further studies on
non-alcoholic fatty liver disease (NAFLD).
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Introduction
Accumulation of lipids (primarily triglycerides) in hepatocytes is
considered a hallmark and pre-requisite for development of non-
alcoholic fatty liver disease (NAFLD) [1]. With increasing
prevalence of obesity among adults and children, NAFLD has
become the most common form of chronic liver disease in
developed countries [2]. Studies have shown that diets rich in
saturated fats contribute significantly towards increasing the risk of
NAFLD [3,4]. Consequently, a large number of studies have
focused on the effects of free fatty acids (FFA) on hepatocytes to
understand the pathogenesis of NAFLD and related liver diseases
(reviewed in [5]). In recent years, systems biology approaches
utilizing high-throughput (microarray) measurements have been
applied to gain significant insights into the cytotoxic effects of FFAs
on hepatocytes using either static [6,7,8,9] or dynamic gene
expression profiles [10]. While these efforts have focused predom-
inantly onidentifyingindividualtargetgenes,some researchershave
suggested a more complex scenario, whereby genes cooperate in
regulating cellular events in response to FFA treatment [11].
In this study, we analyzed the cytotoxic effects of palmitate
treatment, the most common FFA in the diet, on HepG2 cells.
First, we selected a subset of genes affected by FFA treatment by
mapping their gene expression to metabolite profiles [8,12]. This
allowed the integration of multi-level data and further helped to
alleviate the computational burden associated with the analysis of
a large set of gene expression data. Next, we used an integrative
methodology to reconstruct a gene cooperation network using the
concept of ‘‘Information Synergy’’ [13]. The underlying principle
of information synergy states that if two genes cooperate to affect a
phenotype, then the joint expression of these two genes should
provide more information on the phenotype than the sum of the
information contributed independently by each of the genes. Thus,
the gain in information or information synergy could be used to
quantitatively asses the cooperative effect of any two genes on a
phenotype. To help elucidate the processes that may be altered we
analyzed the pathways that were enriched in the network.
Our search for over-represented pathways in the synergy
network recovered insulin signaling pathway as the most
significantly enriched pathway. This is notable given the fact that
almost all patients diagnosed with NAFLD have concomitant
insulin resistance [14]. Ruddock et al. confirmed that palmitate
treatment induces resistance to insulin signaling in hepatocytes
[15]. We further expanded our search to the neighbor genes of the
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e28138insulin signaling pathway in the synergy network and recovered
desmoplakin (DSP), a junction protein, as the top neighbor. The
DSP protein is an obligate component of functional desmosomes
at intercellular junctions. DSP together with plakoglobin and
plakophilin forms the intracellular desmosomal plaque [16], which
serves as an anchor for keratin intermediate filament attachment
[17]. In general, junction proteins are known to be inhibited
during chronic liver diseases, including cirrhosis and hepatitis [18].
It has also been shown that the loss of expression and abnormal
localization of junction proteins, including DSP, is correlated with
progression of HCC [19]. However, the effects of palmitate on
DSP protein expression have not been previously reported.
Here, we investigated the effects of palmitate treatment on the
expression of DSP in HepG2 cells. Furthermore, since DSP was
recovered as a neighbor of insulin signaling pathway, we analyzed
the effect of insulin treatment on DSP expression. We found that
palmitate treatment leads to the loss of DSP expression and
treatment with insulin enhanced the recovery of DSP expression
following palmitate treatment. Thus, our study indicates that the
junction protein DSP, in synergy with insulin signaling, may be a
novel target in the pathology of fatty liver disease.
Materials and Methods
Datasets
HepG2 cells purchased from American Type Culture Collec-
tion (ATCC) were exposed to different FFA treatments for
48 hours. Gene expressions of these treated cells were then
profiled with cDNA Microarrays at the Van Andel Institute
(Grand Rapids, MI) and pre-processed by GenePix Pro 5.0
(Microarray Acquisition and Analysis Software from Molecular
Devices, LLC). The fluxes of 28 metabolites were measured using
either HPLC or kits, and cytotoxicity was evaluated based upon
LDH levels in the supernatants and in the cell lysates. The
procedures of fatty acid treatments, microarray analysis, cytotox-
icity and metabolic fluxes measurement were described in our
previous works [8,12]. The microarray dataset has been deposited
to GEO website [20], with the query number of GSE26885.
Gene selection based on the trend of the metabolites
profiles
FFAs modulate multiple intracellular metabolic pathways, many
of which are involved in the pathophysiology of fatty liver disease.
The fluxes of various metabolites were used to identify four
representative trends across the treatment conditions: bovine
serum albumin (BSA, control), Palmitate and Oleate, as discussed
in [21] (see Figure S1). The gene expressions were first
logrithmized with base 2, and the expressions for the probes
designed for same genes were averaged out. The genes annotated
with unknown functions (i.e. ‘‘EST/hypothetical proteins’’ or
‘‘ORF of unknown functions’’) were removed from the dataset.
Then, the expression patterns of the remaining genes were
matched to the four representative metabolite trends across BSA,
Palmitate and Oleate. We further removed the genes not
differentially expressed between any two of the three conditions
based on two-sample t-test (p-value cutoff set at 0.05). Finally, 610
genes remained (see Table S1) for further analysis.
Calculation of information synergy
An information-theoretic measure was used to quantify the
synergy between the genes. Given two genes, G1 and G2, and a
phenotype P (toxic or non-toxic in our case), the information
synergy between G1 and G2 with respect to the phenotype P is
defined as:
Syn G1, G2; P ðÞ ~ IG 1, G2; P ðÞ IG 1; P ðÞ z IG 2; P ðÞ ½ 
where I(G1;P) is the mutual information between G1 and P,
I(G2;P) is the mutual information between G2 and P, and
I(G1,G2;P) is the mutual information between (G1,G2) and P.
This equation reflects the definition of synergy, the additional
contribution provided by the ‘‘whole’’ as compared to the sum of
the contributions of the individual ‘‘parts’’. Mutual information (I)
was calculated based on a clustering-based method for continuous
expression data [22], on an information synergy scale of [21 1]. A
positive synergy score indicated that two genes jointly provided
additional information on the phenotype, a negative synergy score
indicated that the two genes provided redundant information
about the phenotype, and a zero score indicated that the two genes
provided no additional information on the phenotype.
A permutation test was performed to assess the statistical
significance of the synergy score of the gene pairs. The phenotypes
were randomly permutated to un-correlate the phenotype with the
gene expression profiles, and then the synergy scores were re-
calculated based on the permutated phenotype for all gene pairs. This
process was repeated 1000 times to calculate the p-values of the
synergy score for each gene pair. A Benjamin-Hochberg false
discoveryrateprocedure[23] was applied toadjustthe p-valuesfor all
the gene pairs and thereby control the expected false discoveries.
Finally, 4376 out of the 185745 pairs from the 610 genes were
identified as significant based on a cutoff of 0.05 for adjusted p-values.
Statistical test for over-represented pathways and
pathway-gene associations
A web platform GENECODIS [24] was used to identify the
KEGG pathways overrepresented in the synergy network. The
hyper-geometric test was used to calculate the p-values of the
KEGG pathways in the network, followed by Benjiamin-Hoch-
berg FDR control procedure to obtain adjusted p-values, and
finally the adjusted p-value cutoff was set at 0.05 to determine the
significantly over-represented pathways.
Likewise, hyper-geometric test was also used to determine the
significant neighboring genes for each over-represented pathway
in the network. Given one pathway and one of its neighboring
genes in synergy network, the p-value of this pathway-gene
association was calculated as below:
P { value ~ 1 { h( x v x; N{1, n, k)
Where x is the number of pathway genes connected to the given
gene in the network; N is the number of genes in the network; n is
the number of pathway genes in the network; k is the number of
genes connected to the given genes in the network. For each
pathway, the p-values of its neighbor were adjusted by Benjiamin-
Hochberg procedure, and the adjusted p-value cutoff was set at
0.05 to determine the significantly associated neighbors.
Differential Correlation Network
A differential correlation network was constructed by obtaining
gene-pairs which show significant difference in the correlation
coefficients between phenotypes [25]. Pathway enrichment
analysis and pathway-gene association analysis were performed
as described above for synergy network.
Cell culture and treatment
HepG2 cells were cultured in Dulbecco’s Modified Eagle’s
Medium (DMEM) (Invitrogen) containing 10% fetal bovine serum
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were incubated at 37uC and in 10% CO2 atmosphere. Confluent
cells were treated with 0.7 mM palmitate (Sigma) dissolved in
DMEM culture medium for 48 hours. Cells were treated with
1 nM insulin in culture medium for 24, 48 and 72 hours. DMEM
culture medium was used as control for all treatments.
Immunofluorescence
Cells were fixed in 3.7% formaldehyde for 20 min. Cells were
then washed twice with PBS and treated with 5% Triton-X for
10 min. at room temperature to permeabilize cell membrane. This
was followed by washing twice with PBS and incubation with 1%
BSA to block non-specific protein interactions. The cells were then
incubated with 5 mg/ml anti-rabbit DSP primary antibody
(Abcam ab71690) overnight at 4uC. After washing twice with
PBS, cells were incubated in AlexaFluor-488 (Molecular Probes
A11001) conjugated goat anti-rabbit secondary antibody (green)
for 1 hour at room temperature. Cells were washed with PBS and
cell nuclei were stained (blue) using DAPI (Molecular Probes
D1306) at a concentration of 300 nM for 5 min. Coverslips were
mounted in ProLong Gold (Molecular Probes P36934) and
incubated in the dark for 24 hours.
Confocal imaging was performed on an Olympus FluoView
1000 Inverted IX81 microscope, using a 40X oil objective. Blue
and green images were taken sequentially, using a Kalman
average of 2X. The intensity graph was constructed by
normalizing the total green fluorescence intensity to total blue
fluorescence intensity (to account for the number of cells) in 3
separate fields of view for each sample. Multiple comparisons
between fluorescence levels across different treatment conditions
were performed using one-way ANOVA followed by Tukey’s
HSD post-hoc analysis with p-value cut-off set at 0.05.
Results
1 Information synergy network
Based upon the concept of information synergy, we recon-
structed a gene-cooperation network composed of 570 genes with
4376 connection edges. Topological analysis shows that this
network follows a power-law distribution (see Figure S2) that is
different from the bell-like distribution of a random network. The
reconstructed network suggested potential gene targets and
pathways that may play important roles in the induction of the
cytotoxic phenotype.
Positive information synergy indicates joint association
with phenotype
We interrogated gene pairs in terms of their ability to jointly
distinguish phenotypes. As described above, positive, zero and
negative information synergies represent gene pairs that provide
synergistic, no and redundant information on the phenotype,
respectively. Examples of gene pairs for each level of information
synergy, demonstrating how they jointly provide information on
the phenotypes, are illustrated in Figure 1.
For the gene pairs with significant positive synergy in Figure 1
(top row), neither of the two individual genes was strongly
correlated with the phenotype in the univariate marginal
distribution. On the other hand, the gene pairs were significantly
correlated to the phenotype, i.e. their expressions jointly help to
distinguish the phenotypes. The two phenotypes are clearly
discernible with the existence of a gap, previously denoted as a
‘‘gap’’ pattern [26]. Additional correlation patterns, including
‘‘substitute’’ and ‘‘on/off’’ [26], were also observed in a small
number of positive gene pairs (see Figure S3 for explanations of
these correlation patterns). Thus, both genes in the pair with
positive synergy would have been ignored by a correlation based
one-gene-at-a-time approach which considers only those genes
that are highly correlated to the phenotypes.
2 Enriched pathways related to palmitate induced
cytotoxicity
The pathways enriched in the synergy network were explored
through enrichment analysis. 42 pathways were significantly
enriched in the synergy network (see Table S2), and the top 10
pathways are listed in Table 1.
As seen in Table 1, cellular activities such as insulin signaling,
adherence junction/cytoskeleton regulation, amino acid metabo-
lism, and ubiquitin-mediated proteolysis are highly enriched in the
synergy network. Indeed, it has been suggested in the literature
that palmitate treatment affects several of these enriched
pathways, including insulin signaling inhibited by palmitate in
hepatomal cells [15], ER stress and the ubiquitin mediated
protease pathways [27,28], as well as adherence junction and
cytoskeleton structure [29,30]. Palmitate has been also shown to
modulate the metabolism of various amino acids [12] which may
be important players in palmitate-related cytotoxicity. For
example, arginine metabolism provides substrate for nitric oxide
synthetase (NOS) and palmitate treatment was found to enhance
cell death by increasing NOS activity and NO production [31].
3 Pathway-gene association analysis
In this section, we investigated the associations between the
enriched pathways and their neighbors in the synergy network.
Neighbors were defined as genes in the network connected to at
least one gene of the enriched pathway. The connections in the
network represent cooperative relationships between the genes.
Therefore, we assumed that the neighbor genes, especially those
connected to multiple members of an enriched pathway may
function cooperatively with the enriched pathway in the associated
phenotype.
Neighbor genes relevant to insulin signaling pathway
We evaluated the biological relevance of insulin signaling, the
most significantly enriched pathway, and its neighbor genes. In the
synergy network, there are a total of 262 neighbor genes (see Table
S3) connected to the insulin signaling pathway (Figure 2 and
Figure S4), and most of these neighbor genes (more than 90%) are
connected to one or two insulin signaling genes. We focused on
only those neighbor genes that are connected to 3 or more insulin
signaling genes in the synergy network. For each of these neighbor
genes, the statistical significance of its association with the insulin
signaling pathway was evaluated by the hyper-geometric test. The
neighbor genes significantly associated with insulin signaling are
listed and ranked according to their p-values in Table 2.
4 DSP: the top neighbor
The junction protein, DSP, was recovered as the top-neighbor
of insulin signaling pathway from the synergy network. Loss of
DSP expression has been reported in more severe forms of liver
disease, i.e. cirrhosis and HCC, but this has not been implicated in
the pathology of fatty liver disease. Hence, we investigated the
effects of palmitate treatment on the expression of DSP in HepG2
cells. Since, DSP was recovered as a neighbor of the insulin
signaling pathway, we also studied the effect of insulin treatment
on DSP expression. HepG2 cells were grown to confluency and
treated with palmitate containing media. We observed cellular
expression of DSP by measuring the fluorescence levels of DSP
Synergy Analysis Reveals DSP in Liver Toxicity
PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e28138Figure 1. Joint expression of gene pairs with different information synergy. Blue and red points represent nontoxic and toxic samples,
respectively. From top to bottom: Gene pairs with positive synergy jointly discriminate the phenotypes (indicated by the black dashed lines – joint
information), whereas either of the genes alone provide little information in discriminating the phenotypes (indicated by the data points projectedt o
the axes – marginal information). In contrast, genes with zero information synergy appear to be independent of the phenotypes, both jointly and
marginally. Gene pairs with negative information synergy are marginally informative on the phenotype, such that either of the genes can provide
information on the phenotype, but the additional information provided by the other gene does not enhance the discrimination of the phenotype, i.e.
information provided by both genes about the phenotype is redundant.
doi:10.1371/journal.pone.0028138.g001
Table 1. Top ten KEGG pathways ranked by their p-values enriched in the synergy network.
Pathway names #genes in network p-value Affected by Palmitate
04910: Insulin signaling pathway 15 6.68E-07 Known [15]
04520: Adherens junction 10 2.10E-05 Known [29,30]
00310: Lysine degradation 7 0.00014 Known [12]
00330: Arginine and proline metabolism 6 0.00053 Known [12]
04916: Melanogenesis 8 0.00556
04120: Ubiquitin mediated proteolysis 9 0.00644 Known [28,65]
04010: MAPK signaling pathway 13 0.00658 Known [66]
05210: Colorectal cancer 7 0.00716
04310: Wnt signaling pathway 9 0.00942 Known [67]
04810: Regulation of actin cytoskeleton 11 0.00981 Known [30,68]
doi:10.1371/journal.pone.0028138.t001
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intensity of DSP against nuclear staining was used to quantify and
normalize the amount of DSP under each treatment condition
(Figure 4). Finally, we compared changes in relative DSP
expression between treatment conditions and determined statisti-
cally significant pairs using Tukey’s HSD post-hoc analysis
(Figure 4).
Palmitate reduces DSP expression
First, we evaluated the effect of palmitate treatment on DSP
expression. We treated HepG2 cells with 0.7 mM palmitate for
48 hours and observed the fluorescence levels of DSP (Figure 3B).
When compared to control (Figure 3A), we found that palmitate treated
cells showed a significant decrease in DSP expression levels (p,0.05).
Insulin enhances recovery of DSP expression
Next, we examined the recovery of DSP expression in palmitate
treated cells by removing palmitate after 48 hours of treatment
and adding regular growth medium. The cells were allowed to
grow for another 72 hours (Figure 3C) and showed some recovery
of DSP expression with time, albeit statistically different from
control (p,0.05). To assess the effect of insulin on the recovery of
DSP expression, we treated HepG2 cells with physiological
concentration of insulin (1 nM) [32] for up to 72 hours, following
the removal of palmitate after 48 hours of treatment. Fluorescence
levels of DSP in the cells were analyzed every 24 hours. As seen in
Figure 3D–E, cells treated with insulin for 24 and 48 hours show
partial recovery of DSP levels compared to palmitate treated cells
(p,0.05), but cells treated with insulin for 72 hours show a
Figure 2. Sub-network for insulin signaling genes and their neighbor genes in the synergy network. Yellow nodes represent insulin
signaling genes, and pink, green, blue and black nodes represent the neighbor genes connecting to one, two, three and more insulin signaling genes,
respectively. The fifteen insulin genes, the top three neighbor genes (in Table 2) and the four genes connecting to more than three genes were
labeled with gene names for reference.
doi:10.1371/journal.pone.0028138.g002
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levels of DSP after 72 hours of insulin treatment are statistically
similar to the levels in the control cells (p.0.05). The results
suggest the expression of DSP that was lost upon palmitate
treatment recovered to basal levels by treating the cells with
insulin. Although, cells did recover some expression of DSP after
removal of palmitate from the medium, the recovery was not
restored to basal levels.
Thus, our experiment supports the association of the palmitate-
induced cytotoxic phenotype with the DSP-insulin signaling
pathway in our network. Namely, that DSP and insulin signaling
act synergistically to ensure the proper function of adherence
junctions and the lost or reduction in DSP expression and insulin
signaling by palmitate treatment contributes to the cytotoxic effect
of palmitate. Thus suggesting that in liver cells DSP may be a
novel target of palmitate-induced cytotoxicity.
5 Differential correlation analysis fails to identify DSP
Extant methods based on differential correlation have been used
to uncover phenotype-specific gene interactions [33]. However,
the quality of the data (i.e. sample size or noise level) would affect
the results obtained, i.e. in the correlation coefficients calculated,
Table 2. Neighbors significantly associated with insulin signaling pathway.
Gene
Connections to insulin
signaling Degree (overall network) p-value
Association with insulin
signaling
DSP 3 12 4.18E-03 Unknown
ACADSB 3 12 4.18E-03 Unknown
1
PANK3 3 15 7.50E-03 Known, [69]
SLC39A3 3 18 9.60E-03 Known, [70,71,72]
ICA1 3 20 1.24E-02 Known, [73]
TTYH1 3 30 2.94E-02 Known, [74]
EP400NL 3 31 2.94E-02 Unknown
EGFR 3 36 3.59E-02 Known, [75,76]
C6orf150 3 37 3.59E-02 Unknown
FAM69B 3 37 3.59E-02 Unknown
HOMER2 8 180 4.84E-02 Known, [77,78]
1ACADSB is involved in the metabolism of fatty acids and branch chained amino acids [79]. Prolonged treatment with long chain FFAs, including palmitate, increases
FA oxidation [12,80], which has been proposed to serve as a protective mechanism against the potential toxic effects of long chain fatty acids [80,81]. Insulin, on the
other hand, down-regulates FA oxidation in various cell types [82,83]. Since palmitate can impair the insulin signaling pathway [84], it is reasonable that ACADSB
emerges as a top neighbor of the insulin signaling pathway.
doi:10.1371/journal.pone.0028138.t002
Figure 3. Immuno-fluorescence images of HepG2 cells stained for DSP (green) and cell nuclei (blue) obtained using confocal
microscopy (see methods). Scale bars represent 50 mm. A) Untreated, control cells grown in regular growth media. B) Cells treated with palmitate
for 48 hours show decrease in DSP levels C) Cells treated with palmitate for 48 hours and recovered in normal growth media for 72 hours show
partial recovery of DSP expression. Cells treated with palmitate for 48 hours and recovered in growth media with insulin for D) 24 hours and
E) 48 hours show partial recovery, whereas for F) 72 hours show complete recovery of DSP expression.
doi:10.1371/journal.pone.0028138.g003
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correlation across the phenotypes are real changes or simply an
artifact due to the size or noise level. In contrast, the information
synergy approach takes the phenotype data directly into account,
thus the influence of the difference in the data quality across
phenotypes is less of a concern than in the correlation-based
methods. We compared the performance of information synergy
approach to a standard differential correlation approach [25] for
reconstructing phenotype-specific networks. The statistics for this
comparison are shown in Table 3. As seen in Table 3, the insulin
signaling pathway was recovered as the top pathway in the
differential correlation network. But, DSP was not found to be
significantly associated with the insulin signaling pathway.
We further investigated the ability of genes paired with DSP to
distinguish the two phenotypes. The joint expressions of these gene
pairs are shown in Figure 5. One gene (ACACA) was identified by
both synergy analysis and differential correlation. From Figure 5, it
is evident that the two phenotypes are distinctly separated in the
synergy analysis plots whereas the phenotypes in the correlation
analysis plots do not separate distinctly. Thus, the synergy analysis
was more effective in identifying gene pairs that can distinguish
between phenotypes.
Discussion
We presented an integrative methodology to reconstruct a gene
network that demonstrates cooperativity plays an important role in
complex diseases. There are three major contributions from this
analysis. First, we presented the idea of information synergy and
applied this method to microarray data from palmitate treated
HepG2 cells: a condition relevant to fatty liver disease. Second, we
showed that DSP is a novel target of palmitate treatment. Third,
we showed that insulin impacts DSP expression, and palmitate,
known to antagonize insulin signaling, also negatively impacts
DSP, contributing to the cytotoxic effect of palmitate. Overall, we
suggest that a synergy network-based gene and pathway
association analysis has the potential to reveal novel targets or
mechanisms underlying biological processes, exemplified by the
uncovering of DSP as a novel player in palmitate-induced
cytoxicity.
The concept of synergy is intuitive and relevant to biological
systems. For example, two transcription factors may play a
cooperative role in determining the expression of a common gene.
Similarly, interactions may occur between signaling proteins, i.e.
cross-talk, and such associations may also be seen in receptor
Figure 4. Quantitative effects of palmitate and insulin treatment on DSP expression (see methods). Bars indicate relative expression of
DSP under various treatment conditions. Palmitate treatment significantly decreases DSP expression where as subsequent treatment with insulin
restores DSP expression. Lines represent pairs of condition where changes in DSP level are significant. * indicates significant difference (p,0.05) from
control cells. ** indicates significant difference (p,0.05) from palmitate (48 hours) treated cells.
doi:10.1371/journal.pone.0028138.g004





Statistics for whole network # genes in the network 570 610
# connections in the network 4376 87054
# insulin signaling genes in the network 15 15
Rank of insulin signaling in term of statistical significance in the network 1st 1st
Statistics for DSP Degree of DSP in the network 12 210
# insulin signaling genes connecting to DSP 3 3
FDR adjusted p-value of the association b/w DSP and insulin signaling 4.18E-3 0.882
Rank of DSP among the genes connected to at least three insulin signaling genes
based on statistical significance
1st 549th
doi:10.1371/journal.pone.0028138.t003
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cooperative effects, and in this study, on the impact of these
effects on the induction a particular phenotype. There are several
examples of synergistic interactions implicated in the pathology of
fatty liver disease. For example, Smith J.J et al. showed that two
groups of transcription factors worked in a combinatorial manner
to control the transcriptional responses to fatty acids [34], thus
supporting that cooperativity is important in regulating cellular
processes. Similarly, co-expression of HNF4 and GATA tran-
scription factor could synergistically activate the expressions of two
genes involved in cholesterol homeostasis, and their binding sites
are essential for maximal synergism [35]. Peroxisome proliferator
activated receptors (PPARs), one of the best characterized nuclear
receptors that mediate transcriptional activities of long-chain
unsaturated fatty acids, was found to selectively cooperate with
fatty acid binding proteins (FABPs) to regulate transcription [36].
Sterol receptor element-binding protein (SREBP-1c), a gatekeeper
of lipotoxicity [37], functions together with BETA2, LXRs and
SP1, to regulate various cellular processes, such as insulin signaling
[38], lipid synthesis [39], and cholesterol biosynthesis [40]. It is
evident from these examples that identifying genes with cooper-
ative effects [13], instead of limiting efforts to individual genes, has
the potential to reveal novel genes or interactions, and ultimately
help elucidate the mechanism of progression of complex diseases
such as NAFLD. Along this line, differential correlation based
approaches have been applied to identify linear relationships
between genes and phenotype. However, information synergy has
the distinct advantage in their ability to capture gene pairs with
different types of dependency (not limited to linear correlation), as
long as the gene pairs provide additional information on the
phenotype. This makes it particularly appealing for complex
scenarios such as uncovering gene cooperation in the induction of
a phenotype or disease, where the interactions may not be linear.
Thus, information synergy is a promising approach for construct-
ing phenotype-specific networks, and provides a complementary
approach to correlation-based methods.
Although synergistic gene pairs have been shown valuable in
discriminating phenotypes, interpreting the roles of the individual
gene pairs remains a challenge due to the lack of sufficient
functional or structural annotations for many of the genes, thereby
formulating plausible hypotheses of the gene pairs more difficult.
In contrast, organizing the individual gene pairs into a network
(synergy network) and then performing gene module level analysis
[41], i.e. identifying the pathways over-represented in network or
pathway-gene associations, could help to hint at potential
mechanisms as shown in our study. Nevertheless, investigating
individual gene pairs would still be valuable in the future. Since the
gene pairs identified from the microarray data do not necessarily
interact directly with each other, future investigation of individual
gene pairs coupled with physical interaction data (i.e. protein-
protein and protein-DNA interaction) should further improve the
analysis.
Figure 5. The expressions of gene pairs, namely of insulin signaling genes and DSP. Shown are three pairs of insulin signaling genes
connected to DSP in the synergy analysis (top) and three pairs obtained from the differential correlation analysis (bottom). Red and blue points
represent toxic (treated with palmitate) and nontoxic samples, respectively.
doi:10.1371/journal.pone.0028138.g005
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microarray data obtained from FFA-treated HepG2 cells revealed
insulin signaling as the most significantly enriched biological
pathway. Thus, our analysis successfully recovered insulin
signaling as a hallmark characteristic pathway involved in fatty
liver disease [42]. We further examined and confirmed the effects
of palmitate treatment on DSP, the top synergistic neighbor of
insulin signaling pathway.
Through synergy analysis we found that expression of DSP is
reduced by palmitate treatment in HepG2 cells. DSP is a
desmosomal protein essential for intercellular attachment by
desmosomes. In a study of adhesion molecules in HCC, Cao et
al. found that moderately differentiated hepatocytes tend to show a
reduction in DSP protein expression, whereas poorly differentiated
hepatocytes show complete loss of DSP protein expression [43]. It
has been suggested that DSP expression levels are inversely
correlated with cell growth and division. As shown in a study with
squamous cell carcinoma, inhibition of EGF (epidermal growth
factor) using antagonists led to an increase in DSP protein levels
[44]. Another study has suggested that DSP may play a role in
tumor-matrix interaction as it was found to be a major component
of exosomes secreted by mesothelioma cells [45]. Other studies
have also suggested that loss of desmosomes may be associated
with epithelial to mesenchymal transition (EMT) by means which
hepatocytes may acquire malignant characteristics [46]. Although,
such associations were reported in HCC, our results suggest that
the impact on DSP may be an early event in the pathogenesis of
fatty liver disease. In other words, reduced expression of DSP may
contribute to the progression to more severe forms of liver diseases.
From Table 1 adherens junction was identified as a highly
enriched category in our synergy network. Treatment with
palmitate has been shown to affect cellular adherence and
cytoskeletal structure in hepatocytes [29,30], although the exact
mechanism and whether DSP is involved in mediating these
processes is unknown. Since, keratins require DSP at the
desmosomal plaque for anchoring to the cell membrane [17],
our results open up the possibility that loss of cytoskeletal structure
may be associated with the loss of DSP.
Previous studies have shown that inherited mutations in DSP
are a characteristic feature of a number diseases of the skin and
heart including, skin fragility or wooly hair syndrome [47],
arrhythmogenic right ventricular dysplasia [17,48], lethal acantho-
lytic epidermolysis bullosa [49], and dilated cardiomyopathy with
wooly hair and keratoderma [50]. It is notable that in recent years
some research groups have suggested the risk of cardiovascular
disease (CVD) may be elevated in NAFLD patients [51,52,53].
Given that alterations in DSP expression are associated with heart
disease and since DSP levels are reduced by palmitate treatment, it
raises the possibility that DSP may serve as a potential link
between fatty liver disease and heart disease.
We also explored the relationship between DSP and insulin
signaling and found that insulin treatment enhances the recovery
of DSP expression lost due to palmitate treatment. It is known that
palmitate can induce resistance to insulin signaling in hepatocytes
[15] and several mechanisms have been proposed to explain this
observation. Studies have suggested that PKCA (Protein Kinase C,
alpha isoform), known to be activated by lipids (diacylglycerols)
[54], shares an antagonistic relationship with insulin signaling, and
that knock-out of PKCA enhances insulin signaling [55].
Interestingly, the activation of PKCA also affects the dynamics
of desmosomal complex at plasma membrane [56,57]. Junction
plakoglobin co-localizes with DSP at the desmosomal plaque. It
has been shown in a study with mice cardiomyocytes that
inhibition of DSP expression leads to change in localization of
plakoglobins from cytoplasm to nucleus. This was shown to
antagonize Wnt/b-catenin signaling pathway, and trigger the
accumulation of fat droplets [58]. It is noteworthy that Wnt
signaling is a significantly enriched pathway in the synergy
network (See Table 1). Wnt signaling is frequently attenuated in
HCC patients and is associated with poor prognosis [59].
Furthermore, recent studies have confirmed that activation of
Wnt signaling enhances insulin sensitivity [60,61]. This suggests
that palmitate induced loss of DSP protein can further enhance
insulin resistance through the Wnt/b-catenin signaling pathway.
Thus, it may not be a coincidence that DSP was recovered as a
synergistic pair to the insulin signaling pathway in the network.
According to one estimate, about one-third of the general
population in the United States suffers from NAFLD [62]. Follow
up studies of patients suffering from this burgeoning disease have
shown that their survival is significantly lower than that of the
general population [63]. Furthermore, NAFLD can progress to the
more severe steatohepatitis (NASH) in a number of patients, which
may further develop into cirrhosis and eventually into liver
carcinoma (HCC) [64]. Unfortunately, the factors responsible for
the pathology and progression of liver disease in these patients
remain poorly understood. Our studies confirmed a potential link
between palmitate, insulin signaling and DSP, and are currently
further investigating the mechanisms contributing towards pro-
gression to more severe forms of liver disease.
Supporting Information
Figure S1 Four Representative Trends of the Metabolites.
Eleven metabolites differed significantly across the three conditions
(treated by BSA, Palmitate and Oleate), and four representative
trends were extracted from these metabolites. Trend I: BSA ,
Palm and Palm . Ole; Trend II: BSA . Palm and Palm , Ole;
Trend III: BSA , Palm , Ole; Trend IV: BSA . Palm . Ole.
(TIFF)
Figure S2 Degree distribution of synergy network and Random
network. The random network was generated based on Erdo ¨s-
Re ´nyi model, with same number of nodes and edges as synergy
network. The degree distribution in synergy network is clearly
different with that in random network.
(TIF)
Figure S3 Different types of correlation patterns captured by
synergy analysis. Blue and red points represent nontoxic and toxic
samples, respectively. These patterns were specified in [30], and
their definitions were given below: (1) Gap: gene positively
correlated; phenotype associated with the difference of gene
expression; Substitute: gene negatively correlated; phenotype
associated with the sum of gene expression; (3)On/off: turning
on or off both genes lead to same phenotype.
(TIF)
Figure S4 Subnetwork for insulin signaling pathway (all nodes
labeled with gene symbols).
(TIF)
Table S1 The list of 610 genes selected for synergy analysis.
(DOC)
Table S2 All KEGG pathways significantly enriched in the
synergy network.
(DOC)
Table S3 All neighbor genes significantly associated with insulin
signaling.
(DOC)
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